Terumo announces global commercial launch of K-Pack Embrace™ Active Safety Needle

Co-packing a pre-selected injection needle with a drug product and syringe can significantly reduce the risks to the patient, add convenience for the healthcare professional (HCP) and simultaneously maintain the value proposition of the product for the drug company. Automated co-packing processes require enhanced hard-shell protection of needles for easy handling during co-packing and to maintain needle sterility and performance over the product’s intended shelf life.

The K-Pack Embrace^™ active safety needle is designed specifically for automated co-packing processes with its compact hard-shell case. It is intended for subcutaneous (SC), intramuscular (IM) and intravenous (IV) applications and includes Terumo’s T-Sharp^™ technology with integrated needle shield safety features.

Available in either 1” (25 mm) or 5/8” (16 mm) lengths, the K-Pack Embrace^™ 25-gauge needle is compatible with all ISO 80369-7 male connectors and its color-coded, tamper-evident label includes a 2D barcode (UDI carrier) that supports automated in-line visual inspection.

Nicolas Eon, Global Product Manager, Injection and Infusion Platforms, Pharmaceutical Solutions Division, Terumo CorporationThe K-Pack Embrace^™ active safety needle is a great example of applying our Deviceutical^™ approach that brings devices and pharmaceuticals together for uniquely integrated injectable drug delivery solutions.”

“The K-Pack Embrace^™ design simultaneously protects the healthcare professional, patient and product, all while making the efficiencies of automated co-packing available to our pharmaceutical customers,” continues Marco Chiado Piat, President, Pharmaceutical Solutions Division, Terumo. “This new active safety needle builds protection and safety into a single product that aligns with our goal of producing injectable drug delivery solutions that improve the lives of patients.”

Source:

Terumo Corporation